Filing metadata

Accession number
0001415889-22-012648
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Dec 16, 2022
Reporting period
Dec 14, 2022
Description
Insider transaction

Explore SEC Filings Hub